PITTSBURGH, Jan. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that in accordance with its 2.139 million preferred stock issuance, the Company has declared an initial quarterly dividend of $15.53 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share and the time period from the date of issuance to February 15, 2008) payable on February 15, 2008 to holders of preferred stock of record as of February 1, 2008.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

SOURCE  Mylan Inc.
    -0-                             01/30/2008
    /CONTACT:  Kris King of Mylan Inc., +1-724-514-1800/
    /Web site:  http://www.mylan.com /
    (MYL)

CO:  Mylan Inc.
ST:  Pennsylvania
IN:  HEA MTC
SU:  DIV

JM-CS
-- NEW057 --
5860 01/30/2008 16:30 EST http://www.prnewswire.com